Rockefeller Capital Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
FLAM
GKIM
PIM
Rockefeller Capital Management's TNDM Position: Q2 2026 in Review
Rockefeller Capital Management reduced its Tandem Diabetes Care (TNDM) stake by 40% in Q2 2026, selling an estimated $3.02K and leaving 260 shares worth $3.92K. The position accounts for ﹤0.01% of the portfolio, ranked #4300.
Rockefeller Capital Management first reported a position in TNDM in Q1 2019 and has held it in 20 quarters since. The position peaked at $3.01M in Q2 2020. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- Rockefeller Capital Management held 260 shares of Tandem Diabetes Care worth $3.92K as of Q2 2026.
- Rockefeller Capital Management sold 173 Tandem Diabetes Care shares in Q2 2026, an estimated $3.02K.
- Tandem Diabetes Care made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4300 holding.
- Rockefeller Capital Management first reported a position in Tandem Diabetes Care in Q1 2019 and has held it in 20 quarters since.
- Rockefeller Capital Management's Tandem Diabetes Care position peaked at $3.01M in Q2 2020.
- 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.